The World Health Organization R&D Blueprint aims to accelerate the availability of medical technologies during epidemics by focusing on a list of prioritized emerging diseases for which medical countermeasures are insufficient or nonexistent. The prioritization process has 3 components: a Delphi process to narrow down a list of potential priority diseases, a multicriteria decision analysis to rank the short list of diseases, and a final Delphi round to arrive at a final list of 10 diseases. A group of international experts applied this process in January 2017, resulting in a list of 10 priority diseases. The robustness of the list was tested by performing a sensitivity analysis. The new process corrected major shortcomings in the pre–R&D Blueprint approach to disease prioritization and increased confidence in the results.
CITATION STYLE
Si Mehand, M., Millett, P., Al-Shorbaji, F., Roth, C., Kieny, M. P., & Murgue, B. (2018). World health organization methodology to prioritize emerging infectious diseases in need of research and development. Emerging Infectious Diseases, 24(9), e1–e9. https://doi.org/10.3201/eid2409.171427
Mendeley helps you to discover research relevant for your work.